Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CSIR-Indian Inst. of Chemical Technology PD-L1 compound 17h: sourced facts only. name: "Isothermal titration calorimetry (ITC) confirmed direct binding of both compounds to PD-L1, with 17h exhibiting stronger affinity (Kd = 1.43 μM) compared to 17t (Kd = 19.8 μM)." [PMID:42162747]; target: "Isothermal titration calorimetry (ITC) confirmed direct binding of both compounds to PD-L1, with 17h exhibiting stronger affinity (Kd = 1.43 μM) compared to 17t (Kd = 19.8 μM)." [PMID:42162747]; developer: "Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India; Academy of Scientific and Innovative Research, Ghaziabad 201002, India." [PMID:42162747]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CSIR-Indian Inst. of Chemical Technology PD-L1 compound 17h.